GlassScriptPhysician profile
Sharon D Bond
NPI 1497029185
$617.76
in general payments reported to CMS, 2019-2025
8 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $134 · 2022: $247 · 2024: $92.08 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $137 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $136.59 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $185.45 | 2022 | |
| Janssen Biotech, INC. | $99.99 | 2025 | Erleada |
| E.R. Squibb & Sons, L.L.C. | $92.08 | 2024 | Reblozyl |
| Kite Pharma, INC. | $89.46 | 2021 | |
| Novartis Pharmaceuticals Corporation | $76.23 | 2021-2022 | |
| Caris Mpi, INC. | $44.51 | 2025 | Mi Cancer Seek |
| Pfizer INC. | $15.52 | 2022 | |
| Novo Nordisk INC | $14.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Bond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.